Cardiac Conduction System Disease: Clinical Trials

36 trials for Cardiac Conduction System Disease, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

21 completed, 5 unknown, 4 terminated, 3 recruiting. 36 Phase 1, 11 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 136Completed 21, Unknown 5, Terminated 4, Recruiting 3, Withdrawn 2, Active not recruiting 1
Phase 211Completed 4, Terminated 2, Unknown 2, Active not recruiting 1, Recruiting 1, Withdrawn 1

Follow Cardiac Conduction System Disease: new trials by email Literature Review of Cardiac Conduction System Disease trials Research Report on Cardiac Conduction System Disease

Trials (filtered) newest first · largest first

All 36 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
ATR 1072 in Participants With PRKAG2 Syndrome
ATR 1072 - Cardiac Glycogenosis, Cardiomyopathy
Phase 1 / Phase 2RecruitingAtrium Therapeutics372026-09-142026-09-18
A Study of SGT-501 Gene Therapy in Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)
SGT-501 - Catecholaminergic Polymorphic Ventricular Tachycardia
Phase 1RecruitingSolid Biosciences Inc.182026-02-232026-10-26
To Observe Haemodynamic Parameters Including, Heart Rate, Blood Pressure, Respiratory Rate , and Oxygen Saturation, With or Without Giving Reversal Agent on Extubation, in Patients Receiving Single Shot of Atracurium , and to Observe Post Operative Residual Paralysis and Airway Reflexes in PACU.
Placebo drug ( normal saline ), neostigmine (reversal agent) - Tachycardia, Hypertension
Phase 1 / Phase 2CompletedZiauddin University1002025-03-122025-07-31
Study of LQT-1213 on QTc-induced Prolongation in Healthy Adult Subjects (Part1) and on Congenital Long QT in Patients Diagnosed With Type 2 or 3 Long QT Syndrome (Part 2).
LQT-1213, Placebo, Dofetilide 250 μg Cap - Long QT Syndrome
Phase 1 / Phase 2TerminatedThryv Therapeutics, Inc.422023-03-122025-07-24
A Study of Etripamil in Healthy Subjects
Etripamil Nasal Spray 70mg, Placebo - Healthy Chinese Subjects
Phase 1CompletedCorxel Pharmaceuticals122023-03-072023-04-10
Phase 1 Study of LQT-1213 in Healthy Adults
LQT-1213, Placebo - Long QT Syndrome
Phase 1CompletedThryv Therapeutics, Inc.502022-09-142023-09-26
Dose Escalation for SBRT of Recurrent VT Ventricular Tachyarrhythmia - a Single Center, Phase II Clinical Trial
Dose escalating stereotactic arrhythmia radioablation to treat ventricular tachycardia (VT) - Ventricular Tachycardia
Phase 1RecruitingUniversity of Zurich152022-07-012026-08-21
Percutaneous Inferior Cervical Sympathetic Block for Treatment of Refractory Ventricular Tachycardia
Percutaneous inferior cervical sympathetic block - Ventricular Tachycardia
Phase 1WithdrawnUniversity of Missouri-Columbia2022-07-012023-08-07
SBRT in Chagas Disease Ventricular Tachycardia
Stereotactic Body Radiation Therapy - Ventricular Tachycardia, Chagas Disease
Phase 1 / Phase 2UnknownUniversity of Sao Paulo General Hospital102021-07-142024-07-16
Phase I/II Randomized Study of Stereotactic Ablative Radiotherapy (SABR) Versus Standard of Care for Refractory Structural Cardiac Arrhythmias (SABR-HEART)
stereotactic ablative radiotherapy (SABR), Standard of Treatment - Cardiac Arrhythmia, Cardiac
Phase 1 / Phase 2WithdrawnM.D. Anderson Cancer Center2019-09-122024-02-13
A Study to Investigate the Effect of Single Dose of AZD6094 (600 mg) on Cardiac Repolarization in Healthy Volunteers
AZD6094 200 mg, Placebo, Moxifloxacin - Solid Tumors
Phase 1CompletedAstraZeneca452017-09-062020-02-20
Micra Atrial Tracking Using a Ventricular Accelerometer Study
MARVEL algorithm - Atrioventricular Conduction Block
Phase 1CompletedMedtronic Cardiac Rhythm and Heart Failure702017-07-102018-10-26
Phase I/II Study of EP-guided Noninvasive Cardiac Radioablation for Treatment of Ventricular Tachycardia
stereotactic body radiotherapy (SBRT) - Ventricular Tachycardia, Cardiomyopathy
Phase 1 / Phase 2CompletedWashington University School of Medicine192016-07-012024-08-21
Analysis of Adenosine on Sinus and Atrioventricular Nodal Conduction in the Pediatric Transplanted Heart
Adenosine, Cardiac catheterization - Sinus Bradycardia, Atrioventricular Block
Phase 1CompletedColumbia University802015-07-012018-02-08
Pharmacokinetics of Eleclazine in Adults With Normal and Impaired Renal Function
Eleclazine - Long QT Syndrome
Phase 1CompletedGilead Sciences552015-05-012015-12-22
Pharmacokinetics of Eleclazine in Adults With Normal and Impaired Hepatic Function
Eleclazine - Long QT Syndrome
Phase 1CompletedGilead Sciences492015-03-192019-07-29
Effect of Oral GS-6615 on Dofetilide-Induced QT Prolongation, Safety, and Tolerability in Healthy Adults
GS-6615, Placebo to match GS-6615, Placebo to match dofetilide - Long QT Syndrome
Phase 1CompletedGilead Sciences602015-02-012015-05-20
Race Difference Moxifloxacin-induced QT Prolongation Between Healthy Chinese and Caucasian Volunteers
Moxifloxacin - Cardiac Toxicity
Phase 1UnknownHaiyan Li802014-04-012014-04-21
A Dose Ranging Escalation Study of Tramadol Hydrochloride in Healthy Volunteers
Tramadol HCl, 50 mg, Placebo - Healthy
Phase 1CompletedJanssen Scientific Affairs, LLC302013-08-012014-12-16
Botulinum Toxin Injection to Prevent Ventricular Arrhythmias
Botulinum Toxin - Symptomatic Ventricular Asystolia, Ventricular Tachycardia
Phase 1UnknownMeshalkin Research Institute of Pathology of Circulation302013-06-012015-09-25

Showing 20 of 36. Sign in to see all of them.

Narrower conditions

Long QT Syndrome (13)  ·  Tachycardia, Ventricular (10)  ·  Tachycardia (8)  ·  Arrhythmias, Cardiac (4)  ·  Postural Orthostatic Tachycardia Syndrome (3)  ·  Atrioventricular Block (2)  ·  Cardiomyopathies (2)  ·  Death, Sudden, Cardiac (2)  ·  Orthostatic Intolerance (2)  ·  Pain (2)  ·  Tachycardia, Supraventricular (2)  ·  Agnosia (1)  ·  Andersen Syndrome (1)  ·  Atrial Fibrillation (1)  ·  Cardiotoxicity (1)

Broader conditions

Cardiovascular Diseases (36)  ·  Heart Diseases (36)  ·  Pathological Conditions, Signs and Symptoms (36)  ·  Pathologic Processes (35)  ·  Arrhythmias, Cardiac (32)  ·  Cardiovascular Abnormalities (15)  ·  Congenital Abnormalities (15)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (15)  ·  Heart Defects, Congenital (15)  ·  Tachycardia (11)  ·  Signs and Symptoms (6)  ·  Nervous System Diseases (4)  ·  Neurologic Manifestations (4)  ·  Autonomic Nervous System Diseases (3)

Interventions

eleclazine (4)  ·  Moxifloxacin (3)  ·  Acetazolamide (2)  ·  Radiosurgery (2)  ·  Saline Solution (2)  ·  Sodium Chloride (2)  ·  dofetilide (2)  ·  1-(1-(imidazo(1,2-a)pyridin-6-yl)ethyl)-6-(1-methyl-1H-pyrazol-4-yl)-1H-(1,2,3)triazolo(4,5-b)pyrazine (1)  ·  Adenosine (1)  ·  Atenolol (1)  ·  Atomoxetine Hydrochloride (1)  ·  Botulinum Toxins (1)  ·  Capsules (1)  ·  Cardiac Catheterization (1)  ·  Catheter Ablation (1)

Sponsors

Gilead Sciences (4)  ·  Thryv Therapeutics, Inc. (2)  ·  Aalborg University Hospital (1)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  AstraZeneca (1)  ·  Atrium Therapeutics (1)  ·  Beth Israel Deaconess Medical Center (1)  ·  Biosense Webster, Inc. (1)  ·  Columbia University (1)  ·  Corxel Pharmaceuticals (1)  ·  Foundation for Atlanta Veterans Education and Research, Inc. (1)  ·  Haiyan Li (1)  ·  J. Uriach and Company (1)  ·  Janssen Scientific Affairs, LLC (1)  ·  M.D. Anderson Cancer Center (1)

Countries

United States (22)  ·  Czechia (3)  ·  Spain (3)  ·  China (2)  ·  Denmark (2)  ·  France (2)  ·  Romania (2)  ·  Austria (1)  ·  Belgium (1)  ·  Brazil (1)  ·  Canada (1)  ·  Germany (1)  ·  Italy (1)  ·  Malaysia (1)  ·  Moldova (1)

Top investigators

A. Maziar Zafari, M.D., Ph.D (1)  ·  Asma Abdus Salam, Consultant anaesthesiology (1)  ·  Beny Charbit, MD (1)  ·  Brian McNabb, MD (1)  ·  Eli Gang, MD (1)  ·  Elizabeth Layug, MD (1)  ·  Eric S Silver, MD (1)  ·  Esther G Donado, PhD (1)  ·  Haiyan Li, MD (1)  ·  Italo Biaggioni, MD (1)  ·  Jan Matousek, DO (1)

Results publications

PMID 10492412, PMID 10793602, PMID 12717123, PMID 1356374, PMID 15911704, PMID 17893459, PMID 18547438, PMID 19099294, PMID 19687359, PMID 20576632, PMID 22091288, PMID 23372884, PMID 24002370, PMID 24227635, PMID 24495468, PMID 24606242, PMID 24666686, PMID 24721800, PMID 28450351, PMID 28800628, PMID 29261883, PMID 29758405, PMID 30573962, PMID 30586734, PMID 32673517, PMID 33400845, PMID 33733338, PMID 34667360, PMID 3605668, PMID 37139057, PMID 37941012, PMID 6161627, PMID 9366929, PMID 9793671, PMID 9797517

NIH funding

2014 (2), R01HL059459 (1), U10HD045986 (1), U54NS059065 (1), UL1TR000445 (1)